Switching From Ro to PlexusDx: Cost, Steps, and Timing Without Gaps

Last reviewed: September 11, 2026 Last updated: September 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Switching from Ro's Body Program to PlexusDx requires coordinating your final Ro shipment, completing a new clinical intake, and allowing 7–10 business days for approval and delivery. The core economic difference: Ro separates membership ($149/month on the monthly plan, or prepaid at lower rates) from medication ($149–$299/month for semaglutide, $299–$449/month for tirzepatide, dose-dependent), while PlexusDx charges one flat rate—$189/month for semaglutide injection or $289/month for tirzepatide injection, month-to-month, covering consultation, prescription, medication, and shipping. Over 12 months on comparable month-to-month plans, PlexusDx runs approximately $100–$150 less per month depending on your medication and dose. The switch itself is patient-coordinated: no provider can guarantee dose continuity or zero-day gaps, because both programs require independent clinical review and shipping timelines vary. Start your PlexusDx intake 10–14 days before your Ro refill runs out, communicate your current dose and history clearly, and plan for the possibility of a few days' overlap or a short pause.

At-a-glance: Ro vs PlexusDx

Ro pricing captured September 4, 2026 (ro.co); PlexusDx pricing captured July 17–23, 2026 (plexusdx.com). Medication prices are separate on Ro; all-inclusive on PlexusDx. Verify current rates and dose-specific pricing at checkout.

The full cost picture: membership plus medication

Ro's Body Program architecture splits the monthly bill into two line items: membership and medication. On the monthly plan, membership runs $149/month (with a first-month introductory rate of $39 advertised as of September 4, 2026). Medication—Wegovy pill (oral semaglutide), Zepbound or Mounjaro injection (tirzepatide), Ozempic injection, or Foundayo pill—is billed separately and ranges from $149/month for lower-dose semaglutide up to $449/month for higher-dose tirzepatide, depending on the specific drug and tier. All Ro medications are FDA-approved branded products.

Prepaying six months ($534 upfront) or twelve months ($888 upfront) lowers the membership portion to $89/month or $74/month respectively, but does not reduce medication cost, which remains dose-dependent and billed monthly.

PlexusDx charges one monthly rate that covers the provider visit, prescription, compounded medication, and shipping. Semaglutide injection is $189/month and tirzepatide injection is $289/month on the month-to-month plan, with no membership fee and the same price at every dose. Multi-month commitment options (three-month and six-month) are available at lower per-month rates ($169 and $149 for semaglutide, $269 and $249 for tirzepatide), but the month-to-month structure offers the most direct comparison to Ro's monthly plan.

12-month cost comparison (month-to-month plans)

Semaglutide, lowest dose:

• Ro monthly plan (membership $39 first month, then $149/month; Wegovy pill $149/month): first-year total $3,466; effective monthly $289 (our calculation: [$39 + $149×11 + $149×12] ÷ 12).
• Ro monthly plan, standard (no introductory rate): first-year total $3,576; effective monthly $298 (our calculation: [$149×12 + $149×12] ÷ 12).
• PlexusDx semaglutide injection month-to-month: first-year total $2,268; effective monthly $189.
• Difference: PlexusDx runs $100/month lower (vs Ro with intro rate) or $109/month lower (vs Ro standard), saving $1,198–$1,308 over twelve months (our calculation).

Tirzepatide, lowest dose:

• Ro monthly plan (membership $39 first month, then $149/month; Zepbound $299/month): first-year total $5,266; effective monthly $439 (our calculation: [$39 + $149×11 + $299×12] ÷ 12).
• PlexusDx tirzepatide injection month-to-month: first-year total $3,468; effective monthly $289.
• Difference: PlexusDx runs $150/month lower, saving $1,798 over twelve months (our calculation).

These calculations assume Ro's lowest medication tier throughout. Higher-dose tiers widen the gap further, since PlexusDx pricing does not increase with dose.

Step-by-step: coordinating your switch

Neither Ro nor PlexusDx can transfer a prescription directly on your behalf without your involvement, and both require independent clinical review before issuing a new prescription. The steps below reflect standard telehealth-to-telehealth coordination; specific policies may vary, so confirm details with both providers.

1. Check your Ro refill date and remaining supply. Log into your Ro account or review your last shipment tracking. Note the date your current medication will run out.
2. Start your PlexusDx intake 10–14 days before that date. The intake takes about 60 seconds and asks for your current medication, dose, start date, and medical history. Be specific: "Currently on Wegovy 1.7 mg weekly, started March 2026" gives the reviewing provider context for continuity.
3. Complete the PlexusDx clinical review. A licensed provider reviews your intake within 24–48 hours. Approval is not guaranteed and depends on medical appropriateness, but sharing your current regimen helps the provider assess fit and plan dosing.
4. Receive your PlexusDx prescription and first shipment. Once approved, your medication ships within 3–5 business days via standard carrier. Track the shipment and note the expected delivery date.
5. Pause or cancel your Ro subscription before the next billing cycle. Ro's cancellation terms are stated as "per terms" in published materials; contact Ro support to confirm notice requirements and whether any portion of prepaid membership or unused medication is refundable or creditable. If you are on a prepaid plan, clarify the refund policy for the unused months.
6. Coordinate timing to minimize gaps. Ideally, your PlexusDx shipment arrives before your last Ro dose. If timing is tight, contact PlexusDx support to explain the situation; while no provider can guarantee a specific delivery date, clear communication helps. A brief overlap (having one extra week of Ro medication on hand) is safer than a gap, but do not double-dose—follow your prescribed schedule.
7. Dispose of unused medication properly. If you have Ro medication left over, follow FDA guidelines for safe disposal (mix with unpalatable substance, seal in a bag, discard in household trash, or use a drug take-back location).

Important: PlexusDx providers determine your starting dose independently, based on your intake, history, and clinical guidelines. If you are currently on a maintenance dose (for example, semaglutide 2.4 mg weekly), communicate that clearly in your intake, but understand that the new provider may start you at a lower dose and retitrate for safety. Neither Ro nor PlexusDx guarantees dose continuity across the transition.

What the switch does not guarantee

Transparency about limits is as important as describing the process:

• No guaranteed dose match. Your new PlexusDx provider reviews your history and decides the appropriate starting dose. Even if you request your current dose, clinical judgment and compounding-pharmacy availability govern the decision.
• No zero-day gap guarantee. Shipping, approval timing, and carrier variables mean a brief pause (2–5 days) is possible even with careful planning. One missed weekly dose of semaglutide or tirzepatide is generally well-tolerated, but discuss any concerns with your provider.
• No automatic Ro refund or credit. Ro's published terms state cancellation is "per terms," but specifics about prepaid membership refunds or unused medication credits are not detailed in public-facing materials captured as of September 4, 2026. Contact Ro directly to understand your options before canceling.
• No insurance or prior-authorization transfer. Both Ro and PlexusDx operate on a cash-pay model for the services discussed here. If you had prior authorization or insurance coordination through Ro for a branded medication, that does not carry over to PlexusDx's compounded program.

Service quality and patient experience

Cost is often the primary switching driver, but experience matters when you depend on a provider for ongoing medication. Ro's Trustpilot profile (verified to exist as of September 4, 2026) shows recurring themes in negative reviews: confusion over the separate membership and medication billing structure, frustration with prior-authorization requirements, delays in customer service response, and reports of weaker-than-expected efficacy. One Reddit post from the r/RoBody community (captured September 4, 2026; reddit.com/r/RoBody/comments/1py5dwz/ro_weightloss_meds_are_a_scam/) describes the membership-plus-medication model as unclear and the overall value as poor. These are individual anecdotes and reports, not established facts, but the pattern is consistent enough across platforms to note.

PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com). Common positive themes include transparent pricing, responsive support, and straightforward intake-to-delivery flow. No program is without negative reports, but the review record suggests fewer structural friction points when billing is consolidated into one monthly charge.

When Ro still makes sense

Switching is not the right move for every patient. Consider staying with Ro if:

• You require or strongly prefer FDA-approved branded medication. Ro dispenses Wegovy, Zepbound, Ozempic, Mounjaro, and Foundayo—all FDA-approved products. PlexusDx dispenses compounded semaglutide and tirzepatide from 503A pharmacies; compounded medications are not FDA-approved and FDA does not review them for safety, effectiveness, or quality before marketing. A licensed clinician determines whether a prescription is appropriate for an individual patient.
• You are on a Ro prepaid plan and satisfied with the service. If you prepaid six or twelve months and are past the refund window (if any), the sunk cost may make staying through the commitment period more economical than switching and forfeiting the prepayment.
• You have insurance or prior authorization in place that covers your Ro medication cost. If your out-of-pocket cost on Ro is lower than the cash-pay PlexusDx rate due to insurance, the nominal price difference disappears.
• You value access to Ro's broader medication menu. Ro offers oral semaglutide (Wegovy pill) and oral tirzepatide (Foundayo pill) in addition to injections. As of the captured data, PlexusDx's weight-management protocols focus on compounded injections and oral capsules; confirm current product availability if route of administration is a deciding factor.

Where PlexusDx fits

PlexusDx is built for patients who want predictable monthly costs, no membership fee, and no dose-based price increases. The program fits if:

• You are comfortable with compounded medication. Compounded semaglutide and tirzepatide are not FDA-approved and are not interchangeable with branded Wegovy, Ozempic, Zepbound, or Mounjaro. They are custom-prepared by 503A compounding pharmacies under a licensed provider's prescription.
• You want one flat rate that covers everything. $189/month for semaglutide injection or $289/month for tirzepatide injection includes the provider visit, prescription, medication, and shipping—no separate membership, no dose tiers, no hidden fees.
• You are on or approaching a higher maintenance dose. Because PlexusDx pricing does not increase with dose, the value proposition strengthens as you titrate up. A patient on 2.4 mg semaglutide weekly pays the same $189/month as a patient on 0.5 mg.
• You prefer month-to-month flexibility. No long-term commitment, no prepayment requirement. Multi-month plans (three- and six-month) offer lower per-month rates if you want to lock in savings, but the default is month-to-month.
• You value responsive support and transparent processes. The 4.3-star Trustpilot rating and the frequency of five-star reviews suggest a service model that prioritizes clarity and responsiveness, which matters when coordinating ongoing care.

Methodology and freshness

This comparison draws on Ro's published pricing and program structure captured September 4, 2026 (ro.co), PlexusDx pricing captured July 17–23, 2026 (plexusdx.com), Ro Trustpilot and Reddit review themes captured September 4, 2026, and PlexusDx Trustpilot rating captured September 9, 2026 (trustpilot.com/review/plexusdx.com). The 12-month cost calculations ("our calculation") are derived by summing membership and medication over twelve months and dividing by twelve to produce effective monthly rates; these are our arithmetic, not advertised figures. Ro's dose-specific medication pricing is stated as a range in captured sources ($149–$299/month semaglutide, $299–$449/month tirzepatide); we use the lowest tier for comparison to show the minimum cost differential. Actual cost depends on your prescribed dose and plan. Neither provider's internal prescription-transfer, cancellation-refund, or dose-continuity policies are detailed in public-facing documents captured, so the switching steps reflect standard telehealth coordination practices. Confirm current pricing, dose availability, cancellation terms, and clinical policies with both providers at the time of your decision.

Frequently Asked Questions

Can I transfer my Ro prescription directly to PlexusDx?

No. PlexusDx requires a new clinical intake and independent provider review. You cannot transfer an existing Ro prescription; instead, you complete a PlexusDx intake, a licensed provider reviews your history and current regimen, and—if approved—issues a new prescription. Communicate your current dose and medication clearly in the intake to help the provider assess continuity, but the new provider determines your starting dose independently.

Will I have a gap between my last Ro dose and my first PlexusDx dose?

Possibly. Even with careful planning, shipping timelines, approval processing, and carrier variables can create a gap of a few days. Start your PlexusDx intake 10–14 days before your Ro supply runs out to maximize the chance of overlap. A brief pause (one missed weekly dose) is generally well-tolerated for semaglutide or tirzepatide, but if continuity is critical, discuss timing with your PlexusDx provider during the intake or approval process.

Does PlexusDx match my current Ro dose automatically?

Not automatically. The PlexusDx provider reviews your intake and decides the appropriate starting dose based on your history, current regimen, and clinical guidelines. If you are on a maintenance dose (for example, tirzepatide 10 mg weekly), note that in your intake, but the provider may start you at a lower dose and retitrate. Dose continuity is never guaranteed when switching providers, because each provider exercises independent clinical judgment.

What happens to my unused Ro medication or prepaid membership if I switch?

Ro's cancellation and refund policies are stated as "per terms" in published materials captured as of September 4, 2026, without public-facing detail on prepaid membership refunds or unused medication credits. Contact Ro support directly before canceling to understand whether any portion of a prepaid plan is refundable and whether unused medication can be credited or returned. Dispose of any leftover medication safely per FDA guidelines (mix with unpalatable substance, seal in a bag, discard in household trash, or use a drug take-back program).

Is PlexusDx's compounded medication the same as Ro's branded Wegovy or Zepbound?

No. Compounded medications are not FDA-approved, are not interchangeable with branded drugs, and are not "the same as" Wegovy, Ozempic, Zepbound, or Mounjaro. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. PlexusDx works with licensed 503A compounding pharmacies, and a licensed clinician determines whether a compounded prescription is appropriate for an individual patient. Branded medications undergo FDA approval; compounded medications are custom-prepared under a provider's prescription and do not carry that approval.

Sources

• PlexusDx product pages and pricing (plexusdx.com), captured July 17–23, 2026
• Ro Body Program overview and membership pricing (ro.co), captured September 4, 2026
• Ro medication pricing and plan structures (ro.co), captured September 4, 2026
• Ro Trustpilot profile and review themes (trustpilot.com/review/ro.co), captured September 4, 2026
• PlexusDx Trustpilot rating and review distribution (trustpilot.com/review/plexusdx.com), captured September 9, 2026
• Reddit community feedback, r/RoBody (reddit.com/r/RoBody/comments/1py5dwz/ro_weightloss_meds_are_a_scam/), captured September 4, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.